IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,850,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,962,720 | $16,016,000 | 6.52% |
| Abingworth LLP | 197,300 | $1,610,000 | 1.69% |
| NEXTHERA CAPITAL LP | 85,138 | $695,000 | 0.60% |
| Cormorant Asset Management, LP | 432,990 | $3,533,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 153,000 | $1,248,000 | 0.32% |
| TFS CAPITAL LLC | 102,685 | $838,000 | 0.15% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,227,595 | $10,017,000 | 0.10% |
| Eventide Asset Management | 180,000 | $1,469,000 | 0.09% |
| Focused Wealth Management, Inc | 15,868 | $129,000 | 0.06% |
| Spark Investment Management LLC | 77,500 | $632,000 | 0.06% |